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Although ultraviolet B (UVB) irradiation induces local
immune or systemic immune suppression, depending
on the dose, the immune suppression by ultraviolet A
(UVA) has not been fully investigated. In this study,
we investigated the effect of UVA on the immune
response in vitro and in vivo. The effect of UVA on the
antigen-presenting function of epidermal cells was
measured in terms of antigen-specific T cell prolifera-
tion. A murine epidermal cell suspension was exposed
to UVA in vitro, pulsed with trinitrobenzenesulfonic
acid, and cultured with T cells prepared from syngeneic
mice previously sensitized with trinitrochlorobenzene.
UVA (5–20 J per cm2) suppressed the antigen-
presenting function of epidermal cells in a dose-
dependent manner, accompanied with suppression of
the expression of costimulatory molecules on Langer-
hans cells. In order to investigate the effect of an
The exposure of skin to ultraviolet B (UVB) radiationleads to modulation of various biologic processesthroughout the whole body. UVB-induced immunesuppression is well documented, e.g., in studies oncontact hypersensitivity (Noonan et al, 1981), delayed-
type hypersensitivity (Ullrich et al, 1986), and tumor rejection
(Kripke, 1984). Acute UVB (100 mJ per cm2) (Kripke et al, 1992)
exposure or chronic simulated solar UV (85 J per cm2) (Ho et al,
1991) exposure for 4 wk induced immune suppression in vivo.
UVB (2.5–20 mJ per cm2) irradiation in vitro induced suppression
of Langerhans cell function (Stingl et al, 1981; Simon et al, 1991;
Tang and Udey, 1991; Rattis et al, 1995). In addition, susceptibility
to UVB-induced immune suppression supposedly has a close
relation to the development of skin cancers in humans (Yoshikawa
et al, 1990). The mechanism of the immune suppression induced
by UVB is thought to involve Langerhans cells, which are major
antigen-presenting cells that trap antigens in the skin and trigger
sequential immunologic events (Toews et al, 1980). There have
been many studies of the direct effect of UVB (Simon et al, 1990,
1991) or the indirect effect of soluble factors secreted from UVB-
irradiated keratinocytes (Rivas and Ullrich, 1992; Enk et al, 1993)
on Langerhans cells. Whereas commercially available sunscreens
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antioxidant on the immune suppression, an epidermal
cell suspension was irradiated with UVA in the presence
or absence of glutathione. The suppressions of antigen-
presenting function and ICAM-1 expression were signi-
ficantly prevented by glutathione in a dose-dependent
manner. Further, the effect of UVA on the immune
response at the induction phase of contact hypersensit-
ivity was evaluated in terms of lymph node cell prolif-
eration ex vivo. UVA irradiation suppressed the
endogenous proliferation of lymph node cells in trini-
trochlorobenzene-painted mice, and this suppression
was significantly reversed by the application of gluta-
thione to the skin during irradiation. These results
suggest that UVA-induced immune suppression may
be mediated by reactive oxygen species, at least in
part. Key words: antigen presentation/glutathione/Langer-
hans cells/reactive oxygen species. J Invest Dermatol 112:19–
24, 1999
with a high SPF value can protect the skin from UVB, they are
not always protective against UV-induced immune suppression (Ho
et al, 1992; van Praag et al, 1991; Wolf et al, 1993). Thus, the effect
of ultraviolet A (UVA) that passes through sunscreens on the
immune responses has attracted interest. It is known that UVA
induces DNA damage (Roza et al, 1989), DNA-protein cross-links
(Peak et al, 1985), and membrane damage (Black, 1987; Tyrrell
and Keyse, 1990; Shindo et al, 1994); however, the effect of
UVA on the immune system is still controversial. Under some
experimental conditions, UVA irradiation decreases the number of
Langerhans cells in the skin (Alcalay et al, 1989; Lavker et al, 1995;
Grabbe et al, 1996). UVA (2.5–20 J per cm2) irradiation in vitro
induces suppression of Langerhans cell function (Clement-Lacroix
et al, 1996). There is another study reporting UVA (46 J per cm2)-
induced immune suppression in vivo (Bestak and Halliday, 1996),
but on the other hand it has been found that UVA has no effect
on contact hypersensitivity (Laihia and Jansen, 1994).
Therefore, in order to confirm that UVA can induce immune
suppression, we investigated the effect of UVA on the proliferation
of T cells as a result of antigen-presenting ability of epidermal cells
(Stingl et al, 1978; Braathen and Thorsby, 1980). We also measured
the expression of cell surface molecules ICAM-1, B7–1, and B7–
2 on UVA-irradiated Langerhans cell by flow cytometric analysis,
because they are known to play an important role in antigen
presentation to T cells (Dang et al, 1990; Tang and Udey, 1991;
Gaspari et al, 1993; Symington et al, 1993). Furthermore, UVA is
known to produce reactive oxygen species (Shindo et al, 1993,
1994). To determine whether immune suppression induced by
UVA was due to reactive oxygen species, we investigated the effect
of glutathione on the antigen-presenting function of epidermal
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cells and on ex vivo lymph node cell proliferation (Kimber et al,
1993; Hatao et al, 1994).
MATERIALS AND METHODS
Mice Specific-pathogen-free female C3H/HeN mice were obtained
from the Shizuoka Laboratory Animal Center (Shizuoka, Japan) and were
used at 8–12 wk of age. The following experiments conform to the guide
for the care and use of laboratory in NIH.
Preparation of epidermal cells Epidermal cells were prepared as
described before (Stingl et al, 1981). Briefly, ears from mice were incubated
in a phosphate-buffered saline (GIBCO, Rockville, MD) solution con-
taining 0.5% trypsin (Sigma, St. Louis, MO) for 30 min at 37°C. Epidermal
sheets were removed and teased to produce a single cell suspension of
epidermal cells in a 0.05% deoxyribonuclease 1 (Sigma)-RPMI1640
(GIBCO) solution supplemented with 10% heat-inactivated fetal bovine
serum (GIBCO).
UVA irradiation of epidermal cells Epidermal cells were suspended
in RPMI/10% heat-inactivated fetal bovine serum, in a polystyrene dish
(2 3 106 cells in 3 ml) and irradiated with UVA through a UVB cut filter
(Schott WG335, Shott Glas, Mainz, Germany) in the presence or absence
of glutathione (Sigma). The light source was a bank of six FL20S-BLB
fluorescent tubes with an emission spectrum of 310–410 nm and a peak
at 350 nm (Toshiba, Tokyo, Japan). The irradiance of UVA was about 1.5
mW per cm2 for in vitro irradiation and 5 mW per cm2 for in vivo irradiation.
The UV intensity was measured with a UVR-3036S Radiometer (Torex,
Tokyo, Japan). Sham-treated cell populations served as the control. Cell
viability was assessed by trypan blue exclusion.
Antigen pulsing Epidermal cells suspended in RPMI supplemented
with 10% heat-inactivated fetal bovine serum were incubated for 30 min
at 37°C with 1 mg per ml of 2,4,6-trinitrobenzenesulfonic acid (TNBS;
Sigma). After antigen pulsing, cells were washed three times and resuspended
in RPMI/10% heat-inactivated fetal bovine serum at a concentration of
1 3 106 cells per ml.
Preparation of T cells Mice were sensitized on their ears with 25 µl
of 3% trinitrochlorobenzene (TNCB; Tokyo Kasei, Tokyo, Japan) solution
in acetone:olive oil (4:1 vol/vol) for two consecutive days. Four days after
the last TNCB treatment, regional lymph nodes (auricular lymph nodes)
were excised, and disrupted, and the resulting cell suspension was collected.
Cells were then passed over a nylon fiber column (Wako, Osaka, Japan).
Non-adherent, eluted cells were resuspended at a concentration of 2 3 106
cells per ml. Prepared cells consisted of more than 95% CD41 or CD81
T cells, determined by flow cytometric analysis.
Evaluation of the antigen-presenting function of epidermal
cells Sensitized T cells (2 3 105 per 100 µl) and antigen-primed epidermal
cells (1 3 105 per 100 µl) were mixed and cultured in a 96 well plate for
72 h as described before (Stingl et al, 1981). Eighteen hours before
harvesting, 0.5 µCi of [3H]thymidine (Daiichikagakuyakuhin, Tokyo,
Japan) was added to each well. Radioactivity of [3H]thymidine incorporated
by proliferating cells was measured by a liquid scintillation counter.
Flow cytometric analysis of costimulatory molecules on Langerhans
cells After UVA exposure, the cells were collected, washed, and
cultured for 24 h. Immediately after and at 24 h after UVA irradiation,
the cell-surface molecules were immunostained in PBS supplemented
with 1% fetal bovine serum and 0.2% NaN3 (Sigma). Fluorescein
isothiocyanate-conjugated anti-mouse I-Ak monoclonal antibody, phyco-
erythrin-conjugated anti-mouse CD54 (ICAM-1) monoclonal antibody,
biotin-conjugated hamster anti-mouse CD80 (B7–1) monoclonal antibody,
biotin-conjugated rat anti-mouse CD86 (B7–2) monoclonal antibody
and phycoerythrin-conjugated streptavidin were purchased from
Pharmingen (San Diego, CA). Stained cells were washed three times,
resuspended, and analyzed by a flow cytometer (EPICS XL, Coulter,
Hialeah, FL). Langerhans cells were identified as IAk positive cell subset,
and the expression of costimulatory molecules were evaluated by
double staining.
Lymph node cell proliferation assay The effect of UVA on the
immune system in vivo was evaluated by means of a lymph node cell
proliferation assay modified from a reported ex vivo local lymph node assay
(Hatao et al, 1994). Briefly, the dorsal hair of the mice was depilated by
commercially available hair-remover (Shiseido, Osaka, Japan) and the skin
was irradiated with UVA (130 J per cm2). During the UVA irradiation,
Figure 1. Antigen-pulsed epidermal cells induced proliferation of
T cells enriched from lymph node cell suspensions. T cell proliferation
was evaluated by [3H]thymidine incorporation. EC, intact epidermal cells;
pulsed-EC, pulsed epidermal cells; T, T cell-enriched fraction of lymph
node cells from TNCB-sensitized mice; T 1 TNBS, T cell-enriched
fraction of lymph node cells from TNCB-sensitized mice with added
antigen; T 1 EC, T cell-enriched fraction with epidermal cells; T 1
pulsed-EC, T cell-enriched fraction with pulsed epidermal cells. Data
shown are from one representative experiment out of two independent
experiments that gave similar results (mean 6 SD of triplicate cultures).
15 µl of 3% glutathione solution in 50% ethanol was topically applied
every 2 h. Twenty-four hours after the irradiation, a 3% solution of TNCB
was painted on the irradiated sites. Inguinal lymph nodes were excised 3 d
after sensitization and disrupted. The resulting cells were washed, resus-
pended in RPMI/10% heat-inactivated fetal bovine serum at a concentra-
tion of 5 3 106 cells per ml, and cultured in a 96 well microtiter plate for
24 h. Eighteen hours before harvesting, 0.5 µCi of [3H]thymidine was
added to each well. Endogenous proliferation of the cells was evaluated in
terms of the uptake of [3H]thymidine.
Statistical evaluation of results The statistical significance of differences
in the means of each data was calculated with Student’s t test. Mean
differences were considered to be significant at p , 0.05.
RESULTS
Antigen-pulsed epidermal cells induce proliferation of
T cells enriched from the suspensions of lymph node
cells Intact epidermal cells or pulsed epidermal cells showed a
very low [3H]thymidine incorporation. T cell-enriched fraction of
lymph node cells from TNCB-sensitized mice with or without
TNBS added in the medium did not show proliferation either;
however, T cell-enriched fraction cocultured with pulsed epidermal
cells showed marked proliferation (Fig 1).
UVA exposure inhibits antigen-presenting function of epi-
dermal cells The proliferation of T cells caused from the
antigen presentation by TNBS-pulsed epidermal cells was apparently
inhibited by UVA irradiation (0–20 J per cm2) in a dose-dependent
manner (Fig 2). The cytotoxicity was not observed when epidermal
cells were irradiated with 2.5–5 J UVA per cm2; however, 7.5–
10 J UVA per cm2 decreased viability of epidermal cells (Fig 3).
Similar suppression was observed when epidermal cells were
exposed to UVA either in Hank’s balanced salt solution or in
RPMI/10% fetal bovine serum without phenol red, suggesting that
the major part of the suppression was not due to the phototoxic
effect of phenol red under this condition (data not shown).
UVA exposure inhibits upregulation of accessory molecules
on Ia-positive Langerhans cell The expression of ICAM-1 on
Ia-positive Langerhans cells was increased after 24 h of cell culture,
as reported previously (Tang and Udey, 1991). In this series of
experiments, UVA irradiation clearly inhibited this upregulation of
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Figure 2. Dose-dependent suppression of antigen-presenting
capacity of epidermal cells by UVA irradiation. UVA (0–20 J per
cm2)-irradiated murine epidermal cells were pulsed with TNBS and were
cultured with T cells prepared from syngeneic mice sensitized with TNBC.
The antigen-presenting function of Langerhans cell is expressed in terms
of radioactivity of [3H]thymidine incorporated by proliferating T cells.
Data shown are from one representative experiment out of two independent
experiments that gave similar results (mean 6 SD of triplicate cultures).
The asterisk indicates a statistically significant difference (p , 0.05) between
the UVA-irradiated cells and sham-irradiated cells.
Figure 3. Cell survival of UVA-irradiated epidermal cells. Twenty-
four hours after UVA (2.5–10 J per cm2) irradiation, the viability of
epidermal cells was assessed by trypan blue exclusion. Survival (%) was
determined by use of the following formula: (viability of UVA-irradiated
epidermal cells) 4 (viability of sham-irradiated epidermal cells) 3 100.
ICAM-1 in a dose-dependent manner (Fig 4a). A similar inhibitory
effect was observed for other costimulatory molecules, B7–1 and
B7–2 (Fig 4b, c).
Supernatants harvested from UVA-irradiated keratinocyte
had no effect on the proliferation of T cells In order to
confirm that the suppression is due to the direct effect of UVA
irradiation, supernatants from keratinocyte culture were added to
the coculture media. Supernatants harvested from keratinocyte
culture 24, 48, 72 h after UVA irradiation had no effect on the
proliferation of T cells (Fig 5). Supernatants harvested from
keratinocyte culture 24 h after irradiation also had no effect on
ICAM-1 expression of Langerhans cells either (data not shown).
Protective effect of glutathione against UVA-induced sup-
pression of the antigen-presenting function of epidermal
cells The effects of glutathione on UVA-induced suppression of
Figure 4. Dose-dependent suppression of upregulation of the ICAM-
1, B7–1, and B7–2 expression on Langerhans cell by UVA irradiation.
Freshly isolated and cultured epidermal cells were incubated with fluorescein
isothiocyanate-conjugated anti-Ia antibody and phycoerythrin-conjugated
anti-CD54 antibody for analysis of the ICAM-1 expression (a), and
with fluorescein isothiocyanate-conjugated anti-Ia antibody and biotin-
conjugated anti-CD80 antibody for analysis of B7–1 (b) or biotin-conjugated
anti-CD86 antibody for analysis of B7–2 (c), followed by phycoerythrin-
conjugated streptavidin. Expression (%) of these surface molecules was
calculated by use of the following formula: (fluorescence intensity of UV-
irradiated cultured Langerhans cells – fluorescence intensity of fLangerhans
cells) 4 (fluorescence intensity of sham-irradiated cultured Langerhans
cells – fluorescence intensity of fLangerhans cells) 3 100. Data were
expressed as the mean 6 SD of three independent experiments. The
asterisk indicates a statistically significant difference (p , 0.05) between
the UVA-irradiated cells and sham-irradiated cells.
antigen-presenting function were investigated. The augmented
[3H]thymidine incorporation by T cells was suppressed by 5 J per
cm2 of UVA. This suppression was significantly mitigated by 3 mM
glutathione added to the cell-culture media during irradiation
(Fig 6). One millimolar glutathione showed a less marked, but still
significant, mitigating effect, whereas 0.3 mM glutathione had no
effect. The antigen-presenting function of sham-irradiated cells was
not affected by these doses of glutathione. The same results were
also obtained when epidermal cells were exposed in the medium
without phenol red (data not shown).
Protective effect of glutathione against UVA-induced sup-
pression of the surface ICAM-1 expression on Langerhans
cells In order to elucidate the mechanism of the mitigating effect
of glutathione on the antigen-presenting function, the effect of
glutathione on the UVA-induced suppression of surface ICAM-1
expression was investigated by flow cytometry. The dose-dependent
suppression of ICAM-1 expression by UVA was significantly
mitigated by glutathione (Fig 7). Three millimolar glutathione
almost blocked the suppression induced by 2.5 J per cm2 of UVA.
Furthermore, the suppression of ICAM-1 expression induced by
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Figure 5. Effect of supernatants from UVA-irradiated epidermal
cells on Langerhans cell function. Intact epidermal cells and T cells
were cocultured in the supernatants harvested from UVA-irradiated or
unirradiated epidermal cells that had been cultured for 1–3 d after irradiation.
Data shown are from one representative experiment out of two independent
experiments that gave similar results (mean 6 SD of triplicate cultures).
Figure 6. Protective effect of glutathione against UVA-induced
suppression of Langerhans cell function. Epidermal cells suspended in
RPMI/10% fetal bovine serum were irradiated with UVA (5 J per cm2)
in the presence (0.3–3 mM) or absence of glutathione. Data are from one
representative experiment out of two independent experiments (mean
6 SD of triplicate cultures). The asterisk indicates a statistically significant
difference (p , 0.05) between the glutathione treated cells and untreated
cells.
5 J per cm2 of UVA was reversed by glutathione in a dose-
dependent manner, though 0.3 mM glutathione did not have a
significant effect (Fig 8).
Evaluation of immune suppression induced by in vivo UVA
irradiation At the induction phase of contact hypersensitivity,
T cells proliferate at the regional lymph node upon receiving an
immunogenic signal from antigen-presenting cells. Thus, endogen-
ous lymph node cell proliferation has been used for the assessment
of allergenicity of chemicals (Hatao et al, 1994). We employed this
method to investigate the in vivo effect of UVA on the immune
system. In vivo irradiation with UVA at 130 J per cm2 significantly
decreased the endogenous proliferation of inguinal lymph node
cells prepared 24 h after irradiation. The topical application of
glutathione during the irradiation showed a protective effect (Fig 9).
Figure 7. Protective effect of glutathione against UVA (2.5–10 J per
cm2)-induced suppression of ICAM-1 expression. Epidermal cells
were irradiated with UVA (2.5–10 J per cm2) in the presence or absence
of 3 mM glutathione. The ICAM-1 expression (%) was calculated as
described in the legend to Fig 2. Data were expressed as the mean 6 SD
of three independent experiments. The asterisk indicates a statistically
significant difference (p , 0.05) between the glutathione treated cells and
untreated cells.
Figure 8. Dose-dependent protective effect of glutathione against
UVA-induced suppression of ICAM-1 expression. Epidermal cells
were irradiated with UVA (5 J per cm2) in the presence (0.3–3 mM) or
absence of glutathione. [The ICAM-1 expression (%) was calculated as
described in the legend to Fig 4.] Data are expressed as the mean 6 SD
of three independent experiments. The asterisk indicates a statistically
significant difference (p , 0.05) between the glutathione treated and
untreated cells.
DISCUSSION
Many studies have shown that UVB suppresses the immune
function. Because Langerhans cell plays an important role in the
cutaneous immune response, the effect of UVB on Langerhans cell
has been extensively investigated (Toews et al, 1980; Simon et al,
1990, 1991; Enk et al, 1993); however, there have been only a few
studies regarding the effect of UVA on the immune response
(Beasley et al, 1996; Bestak and Halliday, 1996). Clement-Lacroix
et al reported the UVA-induced suppression of allogeneic MELR
and observed a protective effect of vitamin E in human epidermal
cells in vitro (Clement-Lacroix et al, 1996). Bestak et al suggested
that protection against immune suppression by sunscreens is not
related to the sun protection factor, but rather to the sunscreens
having a broad absorption spectrum (Bestak et al, 1995). In this
study, epidermal cells from mice were exposed to UVA in vitro and
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Figure 9. Protective effect of glutathione against the suppression
of endogenous proliferation of lymph node cells induced by in vivo
UVA irradiation. The back of mice was exposed to 130 J per cm2 UVA.
During irradiation, 15 µl of 3% glutathione solution or vehicle was topically
applied every 2 h. TNCB was applied to the irradiated sites on the next
day. Radioactivity of [3H]thymidine incorporated by regional lymph node
cells was measured 3 d after sensitization. Data are from one representative
experiment out of three independent experiments that gave similar results
(mean 6 SD of triplicate cultures). The asterisk indicates a statistically
significant difference (p , 0.05) between the glutathione treated cells and
untreated cells.
the effects of UVA on antigen-presenting function of epidermal
cells and expression of costimulatory molecules on Langerhans
cell were investigated. We showed that UVA irradiation dose
dependently decreased the ability of epidermal cells to present
antigen to T cells directly. This phenomenon was accompanied
with suppression of the expression of accessory molecules (ICAM-
1, B7–1, B7–2). Thus, it is suggested that the suppression of
antigen-presenting function may be due to the suppression of
accessory molecule expression. We also showed that 130 J per cm2
of UVA irradiation in vivo decreased the endogenous proliferation
of lymph node cells. These in vitro and in vivo data suggest that
UVA suppresses the immune response by modulating Langerhans
cell function.
As UVA is known to produce reactive oxygen species, these
species may play a role in the phenomena described here. Cells
have several natural defense systems against oxidative stress, but
they cannot always prevent oxidative stress induced by UVA
irradiation (Shindo et al, 1993, 1994). Among the endogenous free
radical scavengers, glutathione plays a major role in preventing
UVA-induced oxidative stress (Tyrrell and Pidoux, 1986, 1988).
Studies with mouse skin showed that cutaneous glutathione rapidly
decreased following UVA irradiation (Wheeler et al, 1986; Connor
and Wheeler, 1987). We evaluated the effect of exogenous gluta-
thione on UVA-induced immune suppression to establish whether
reactive oxygen species are involved.
Suppression of the antigen-presenting function of epidermal cells
and the ICAM-1 expression on Langerhans cell induced by UVA
(5 J per cm2) was clearly prevented by the addition of glutathione,
in a dose-dependent manner. Glutathione was included in the
culture media only during UVA irradiation, and has no absorption
in the UVA range. Also, 5 J per cm2 of UVA was not cytotoxic to
epidermal cells. These results support the participation of reactive
oxygen species in the suppression of the antigen-presenting function
of Langerhans cell.
Previous studies have shown that UV induces cellular damage
at the plasma membrane, and that subsequent signal transduction
activates NF-κB or AP-1 (Devary et al, 1992, 1993). N-Acetyl-
cysteine, a precursor of glutathione, added to the cellular medium
was transported into the cells and increased the intracellular level
of glutathione (Meister, 1991). The increased glutathione protected
the plasma membrane from UV-induced damage (Devary et al,
1993). In general, intracellular glutathione is exported from the
cytosol to the surrounding medium (Bannai and Tsukeda, 1979),
but extracellular glutathione is not transported into the cell, except
by an Na1-dependent glutathione transport system found in
intestine (Linder et al, 1984) and kidney (Lash and Jones, 1984).
In our study, most of the glutathione added to the medium might
not have been taken up by epidermal cells, but presumably protected
the plasma membrane externally against reactive oxygen species.
This hypothesis remains to be confirmed.
In addition to these in vitro experiments, we demonstrated that
glutathione applied to the skin partially prevented the UVA-induced
immune suppression in vivo. We believe this preventive effect of
glutathione should be based on an antioxidative mechanism either
at the surface of the skin or inside the skin, because glutathione
does not have absorption at UVA range.
Furthermore, in a previous study, vitamin E was found to be
effective in reversing the UVA-induced suppression of allogeneic
MELR (Clement-Lacroix et al, 1996). As vitamin E is also an
antioxidant, it seems likely that antioxidants may generally be
effective to prevent UVA-induced immune suppression. Thus, we
consider that UVA impairs the immune system at least partially via
an oxidative pathway. If this is so, the application of sunscreens
containing antioxidants, such as glutathione, should be effective in
preventing the immune suppression induced by UV.
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